Cytokeratin alterations as diagnostic and prognostic markers of oral and pharyngeal carcinomas. A prospective study.

被引:24
作者
Depondt, J
Shabana, AH
Sawaf, H
Gehanno, P
Forest, N
机构
[1] Univ Paris 07, Inst Biomed Cordeliers, Lab Biol Odontol, F-75270 Paris 06, France
[2] Hop Bichat Claude Bernard, Dept Otolaryngol Head & Neck Surg, F-75877 Paris 18, France
关键词
epithelium; immunohistochemistry; two-dimensional gel electrophoresis;
D O I
10.1046/j.0909-8836.1999.eos107605.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Cytokeratin (CK) alterations have been reported in carcinomas from different anatomical sites, and these have been associated with specific aspects of tumour behaviour. In order to assess the relationships between CK modifications and future tumour behaviour, we conducted the present prospective study on 26 squamous cell carcinomas (SCC) of oral and pharyngeal mucosae and corresponding controls. Cytokeratins were investigated using two-dimensional gel electrophoresis and immunofluorescence techniques. All healthy tissues, oral lining and oropharyngeal mucosae, expressed the oesophageal type CKs, including CK 19. Other simple epithelial CKs (7, 8, 17 and 18) were not detected. In carcinomas originating from corresponding sites, expression of oesophageal CKs varied widely from one specimen to another, and simple epithelial keratins were often found. Statistical analysis indicated correlations between CK expression and the clinicopathological data of SCC patients. Small tumour size was strongly associated with the expression of CKs 10 and 19. interestingly, an absence of lymph node involvement was significantly associated with CK 18 expression. Tumours giving rise to recurrences, metachronous tumours, and distant metastasis were significantly associated with an absence of CK 13. These results suggest that CKs 10, 19, 18 and 13 could be reliable diagnostic and prognostic markers in the assessment of oral and pharyngeal squamous carcinomas.
引用
收藏
页码:442 / 454
页数:13
相关论文
共 68 条
[1]  
ABE K, 1989, BIOMED BIOCHIM ACTA, V48, P393
[2]  
ACHTSTAETTER T, 1986, METHOD ENZYMOL, V134, P355
[3]  
ANSINK A, 1995, CANCER, V76, P638, DOI 10.1002/1097-0142(19950815)76:4<638::AID-CNCR2820760415>3.0.CO
[4]  
2-M
[5]   Cytokeratin 18 expression in squamous cell carcinoma of the head and neck [J].
Balm, AJM ;
Hagman, PC ;
vanDoornewaard, MH ;
Groeneveld, EM ;
Ivanyi, D .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 1996, 253 (4-5) :227-233
[6]   TISSUE-SPECIFIC EXPRESSION OF KERATIN PROTEINS IN HUMAN ESOPHAGEAL AND EPIDERMAL EPITHELIUM AND THEIR CULTURED KERATINOCYTES [J].
BANKSSCHLEGEL, SP ;
HARRIS, CC .
EXPERIMENTAL CELL RESEARCH, 1983, 146 (02) :271-280
[7]  
Bongers V, 1996, J PATHOL, V178, P284
[8]   CIRCULATING FRAGMENTS OF CYTOKERATIN-19 IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA [J].
BONGERS, V ;
BRAAKHUIS, BJM ;
SNOW, GB .
CLINICAL OTOLARYNGOLOGY, 1995, 20 (05) :479-482
[9]   CYTOKERATIN EXPRESSION IN NORMAL SALIVARY-GLANDS AND IN CYSTADENOLYMPHOMAS DEMONSTRATED BY MONOCLONAL-ANTIBODIES AGAINST SELECTIVE CYTOKERATIN POLYPEPTIDES [J].
BORN, IA ;
SCHWECHHEIMER, K ;
MAIER, H ;
OTTO, HF .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1987, 411 (06) :583-589
[10]   EXPRESSION OF SIMPLE EPITHELIAL TYPE CYTOKERATINS IN STRATIFIED EPITHELIA AS DETECTED BY IMMUNOLOCALIZATION AND HYBRIDIZATION INSITU [J].
BOSCH, FX ;
LEUBE, RE ;
ACHTSTATTER, T ;
MOLL, R ;
FRANKE, WW .
JOURNAL OF CELL BIOLOGY, 1988, 106 (05) :1635-1648